Loading...
Loading...
Browse all stories on DeepNewz
VisitWhat will be the outcome of mRNA vaccine safety investigations in Australia by end of 2025?
No issues found • 25%
Minor issues found • 25%
Significant issues found • 25%
Undetermined • 25%
Official reports or findings from Australian health authorities or independent scientific bodies
Australia Opens First mRNA Vaccine Facility, Government Maintains Vaccine Use Amid Safety Concerns
Dec 4, 2024, 07:43 AM
The Australian government has announced that it will not suspend the use of mRNA COVID-19 vaccines, despite concerns raised by some scientists regarding potential health risks, including an increased risk of cancer. This decision coincides with the opening of Australia's first mRNA vaccine manufacturing facility, which has the capacity to produce up to 100 million vaccine doses annually. The facility is intended to bolster the country's ability to protect its population from illnesses and diseases. Vaccine skepticism persists among segments of the population, as debates about the safety and efficacy of mRNA technology continue.
View original story
No changes recommended • 25%
Some vaccines recommended for elimination • 25%
Enhanced safety protocols recommended • 25%
Comprehensive overhaul of vaccine policies • 25%
No contamination detected • 25%
Low levels of plasmid DNA detected • 25%
Moderate levels of plasmid DNA detected • 25%
High levels of plasmid DNA detected • 25%
Confirms higher SAE rate in early batches • 25%
Confirms no difference in SAE rates • 25%
Finds other contributing factors • 25%
Inconclusive results • 25%
No issues found • 25%
Minor issues found • 25%
Moderate issues found • 25%
Severe issues found • 25%
Revised guidelines • 25%
Increased studies • 25%
No change • 25%
Other actions • 25%
Yes • 50%
No • 50%
CDC • 25%
WHO • 25%
Both • 25%
Neither • 25%
CDC • 25%
WHO • 25%
NIH • 25%
Other • 25%
Yes • 50%
No • 50%
No change in safety guidelines • 25%
Minor safety warning issued • 25%
Major safety warning issued • 25%
Vaccine approval revoked • 25%
Increased confidence • 25%
Decreased confidence • 25%
No change • 25%
Mixed opinions • 25%
Influenza • 25%
Other • 25%
HIV • 25%
Cancer • 25%